Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-017941
Date:2021-03-02
Issuer: SYNEOS HEALTH, INC. (SYNH)
Original Submission Date:

Reporting Person:

MACDONALD ALISTAIR
C/O SYNEOS HEALTH, INC.
1030 SYNC STREET MORRISVILLE, NC 27560

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
CLASS A COMMON STOCK 2021-03-02 A 7,993 a $0.00 205,586 direct
CLASS A COMMON STOCK 2021-03-02 A 4,308 a $0.00 209,894 direct
CLASS A COMMON STOCK 2021-03-02 F 14,692 d $75.50 195,202 direct
CLASS A COMMON STOCK 2021-03-02 M 36,429 a $0.00 231,631 direct
CLASS A COMMON STOCK 2021-03-02 F 17,122 d $75.50 214,509 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
PERFORMANCE RESTRICTED STOCK UNITS 0.0 2021-03-02 deemed execution date M 36,429 (d) class a common stock 36,429 $0.00 0 direct
Footnotes
IDfootnote
f1 represents performance restricted stock units that were earned based upon performance criteria for the year ended december 31, 2020 and will vest in full once the compensation and management development committee (the "committee") of the board of directors of syneos health, inc. determines the attainment level of the performance goals for the year ended december 31, 2021, subject to continued employment.
f2 represents performance restricted stock units that were earned based upon performance criteria for the year ended december 31, 2020 and will vest in full once the committee determines the attainment level of the performance goals for the year ended december 31, 2022, subject to continued employment.
f3 represents performance restricted stock units that were earned based upon the achievement of $100 million of defined synergy savings on an annual run-rate through december 31, 2020, as determined by the committee on march 2, 2021.
WhaleWisdom Logo

Elevate your investments